Literature DB >> 7454202

The mode of action of Vinca alkaloids.

O Csuka, J Sugár, I Pályi, S Somfai-Relle.   

Abstract

P388 leukemia-bearing mice were given a single i.p. injection of [14C]-vincristine and the levels of radioactivity in the tumors and host tissues were determined as a function of time. The highest levels of radioactivity were found in the gallbladder followed by the tumor, spleen and liver, respectively. 24 h after drug administration the tumor contains 5.8% of the radioactivity detected in the tumor 1 h after drug administration. The tumor thus does not retain the alkaloid for a long period of time. At subcellular level tubulin was found to bind the highest amount of the alkaloid, followed by the fraction containing Golgi and plasma membranes. P388 tumor sensitive to vincristine (VCR) and formyl-leurosine (F-leu) incorporates three times more VCR and four times more F-leu than the resistant line of the same tumor. The different drug uptake as well as the different Vinca alkaloid binding capacity of membrane fractions of the sensitive and resistant P388 leukemias suggests that the composition and/or the structure of the cell membrane has changed in the resistant line. Vinca alkaloid-induced cell cycle changes were evaluated by cytophotometry. The cytotoxic effect of Vinca alkaloids does not correlate with their ability to arrest cells in metaphase. Multinuclear cells showing higher policy could be detected in the later phase of the treatment; these cells are the representatives of the surviving population. Selective killing of G1 cells is supposed to be a possible way of the cytotoxic action of Vinca alkaloids.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7454202     DOI: 10.1159/000225502

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  5 in total

Review 1.  Intrathecal vincristine: a fatal chemotherapeutic error with devastating central nervous system effects.

Authors:  P G Bain; P L Lantos; V Djurovic; I West
Journal:  J Neurol       Date:  1991-07       Impact factor: 4.849

Review 2.  Clinical management of cytotoxic drug overdose.

Authors:  L L Thomas; M J Mertens; A E von dem Borne; C J van Boxtel; C H Veenhof; E P Veies
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jul-Aug

3.  Decreased retention of vinca alkaloids in chronic lymphatic leukemia cells from refractory patients.

Authors:  M Beksac; C Peterson; P Reizenstein
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

4.  Treatment of artificially-induced pulmonary metastases with fractionated doses of vincristine and/or radiation therapy.

Authors:  D J Grdina; R A White
Journal:  Clin Exp Metastasis       Date:  1983 Jan-Mar       Impact factor: 5.150

5.  Cytotoxic effects of vincristine on tumour subpopulations separated from pulmonary nodules.

Authors:  D J Grdina; R A White; J J Stragand
Journal:  Br J Cancer       Date:  1983-08       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.